Skip to main content
. 2024 Dec 5;25:308. doi: 10.1186/s13059-024-03435-z

Table 1.

Patient cohorts for this study

N
Patients 21
Samples
 Tumor 18
 Stroma 21
Treatments (patients)
 Ipi-Nivo 2 (4)
 Pembo-Axi 4 (7)
 None 15 (28)
Sarcomatoid: IO naïve
 No 8 (14)
 Yes 7 (14)
Median Survival (months)*
 Pre-IO Non-Sarcomatoid 69.5
 Pre-IO Sarcomatoid 29.9
 Post-IO 15.2

*Days divided by (365.25/12)